2015-03-30  facebook twitter rss

New Anti-Inflammatory Cattle Pour-On a World First

It’s now easier for farmers to administer a proven non-steroidal anti-inflammatory drug (NSAID) to their cattle, thanks to the launch of an innovative new product that can be absorbed through the skin.

New FINADYNE Transdermal from MSD Animal Health (known as Merck Animal Health in the United States and Canada) has been granted a transdermal licence for treating bovine respiratory disease, making it the world’s first non-parasiticide cattle product to become available as a pour-on.

Finadyne Transdermal Group

Finadyne Transdermal Group

“Uniquely, FINADYNE Transdermal combines rapid efficacy with its novel, needle-free administration route. After applying to the skin it works fast – as quickly as two hours after treatment,” explains Dr. Martin Behr, technical manager at MSD Animal Health.

“The availability of this innovative new product means cattle producers will no longer have to struggle with the difficulty of injecting cattle showing signs of pneumonia. In addition, use of a pour-on NSAID means no needle-site lesions that can reduce the value of a carcass or compromise hide quality.”

Dr. Behr adds that the time taken by cattle producers to handle and treat animals should be much reduced by using a transdermal NSAID.  Farmers will also make savings on syringes and needles.

The new pour-on comes in pre-calibrated packaging and uses a bottle that’s designed for easy and accurate application along an animal’s back.

FINADYNE Transdermal has received a POM-V classification. Further information is available from veterinary practices.

MSD

  Related Links
link Neospora Incidence Increases Significantly
link NI Suckler Beef Farmer Co-Researchers Wanted!
link Poor Demand for Simmentals at Dungannon
link Red Meat “Vital” to a Balanced Diet


Stackyard News   xml